申请人:Takeda Pharmaceutical Company Limited
公开号:EP1810677A1
公开(公告)日:2007-07-25
The present invention relates to a GPR40 receptor function regulator comprising a fused imidazole compound represented by the formula:
wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof. The GPR40 receptor function regulator is useful as an agent for the prophylaxis or treatment of obesity, hyperinsulinemia, type 2 diabetes and the like.
本发明涉及一种GPR40受体功能调节剂,其包括由下式表示的融合咪唑化合物:
其中每个符号如规范中定义,或其盐或前药。该GPR40受体功能调节剂可用作预防或治疗肥胖、高胰岛素血症、2型糖尿病等的药剂。